OCT News and Research

RSS

Targeting specific signaling pathway could provide new avenue for treating fetal alcohol syndrome

Fetal alcohol spectrum disorders are an array of conditions that can occur in a person whose mother consumed alcohol during pregnancy. Fetal alcohol syndrome, the most severe of these conditions, often results in physical abnormalities, behavioral development issues and intellectual disabilities.

24 Oct 2018

MIT neuroscientists discover how the brain overcomes its difficulties

Imagine trying to write your name so that it can be read in a mirror. Your brain has all of the visual information you need, and you're a pro at writing your own name.

24 Oct 2018

Scientists identify new target for battling deadly form of leukemia

UT Southwestern scientists, working with colleagues at a sister institution in Houston, have identified a new target for battling a deadly form of leukemia.

24 Oct 2018

Researchers engineer new 'smart' repellent surface coatings

Researchers at McMaster University have solved a vexing problem by engineering surface coatings that can repel everything, such as bacteria, viruses and living cells, but can be modified to permit beneficial exceptions.

24 Oct 2018

Hippocampal-avoidance whole-brain radiotherapy better preserves patients' cognitive function

When it comes to radiation therapy to treat brain cancer, hippocampal-avoidance whole-brain radiotherapy in conjunction with the drug memantine better preserved patients' cognitive function and demonstrated similar cancer control outcomes, compared to traditional whole-brain radiotherapy with memantine.

24 Oct 2018

Neurons in the brain's primary visual cortex can reliably detect straight lines

Single neurons in the brain's primary visual cortex can reliably detect straight lines, even though the cellular makeup of the neurons is constantly changing, according to a new study by Carnegie Mellon University neuroscientists, led by Associate Professor of Biological Sciences Sandra Kuhlman.

24 Oct 2018

Scientists develop nanodevice to deliver immunotherapy without side effects

Houston Methodist scientists have developed a nanodevice to deliver immunotherapy without side effects to treat triple-negative breast cancer.

24 Oct 2018

Dyslexia gene linked to concussion susceptibility in athletes

A gene associated with dyslexia, a learning disorder, may make some athletes less susceptible to concussions, reports a new study from Penn State University and Northwestern Medicine.

24 Oct 2018

Family acceptance of LGBT individual's sexuality linked to lower stress

Ohio University Associate Professor of Psychology Dr. Peggy Zoccola has determined that those who identify as LGBT and have come out to their family carry less stress hormones than those who have not come out, which may ultimately benefit their health.

24 Oct 2018

In-home physical therapy care for knee replacement patients leads to better recovery

A team of physical therapy researchers from the University of Colorado School of Medicine have conducted one of the first full-scale studies to assess the effectiveness of in-home physical therapy care for patients who have had knee replacement surgery.

24 Oct 2018

Simple technology prevents infectious disease outbreaks in low-resource settings

A pilot study in which healthcare workers in the Central African Republic used a smartphone app to transmit public health disease reports to health authorities demonstrates that this technique contributes to early detection and prevention of infectious diseases and outbreaks.

24 Oct 2018

Fixing Obamacare’s ‘family glitch’ hinges on outcome of November elections

Last Christmas Eve, Justine Bradford-Trent slipped on ice, slamming to the ground. Her elbow swelled. Was it broken? She couldn't tell.

23 Oct 2018

Novel blood test shows promise for monitoring HPV-linked head and neck cancer after treatment

A new blood test developed by University of North Carolina Lineberger Comprehensive Cancer Center researchers shows promise for tracking HPV-linked head and neck cancer patients to ensure they remain cancer-free after treatment.

23 Oct 2018

FDA targets 465 websites that sell potentially dangerous, unapproved drugs

The U.S. Food and Drug Administration, in partnership with international regulatory and law enforcement agencies, acted this week to target 465 websites that illegally sell potentially dangerous, unapproved versions of opioid, oncology and antiviral prescription drugs to U.S. consumers.

23 Oct 2018

Scientists develop new class of compounds for treatment of progressive neurodegenerative disorder

St. Jude Children's Research Hospital investigators have developed a new class of compounds that extended the lives and eased symptoms of mice with a progressive neurodegenerative human disorder.

23 Oct 2018

'Brain training' app could help OCD patients to manage symptoms

A 'brain training' app developed at the University of Cambridge could help people who suffer from obsessive compulsive disorder manage their symptoms, which may typically include excessive handwashing and contamination fears.

23 Oct 2018

Advanced breast cancer patients can benefit from immunotherapy-chemotherapy combination

Patients with an aggressive form of advanced breast cancer can benefit from immunotherapy when used in combination with chemotherapy as first-line treatment, according to the results of a large international Phase III clinical trial published today in the New England Journal of Medicine and led by a researcher at the UPMC Hillman Cancer Center and the University of Pittsburgh School of Medicine.

23 Oct 2018

Novartis: Lancet publishes pioneering study of Aimovig’s efficacy in episodic migraine patients

Novartis announced today that the full data from the LIBERTY study of Aimovig (erenumab) in episodic migraine patients who had tried and failed two to four prior preventive treatments have been published in the Lancet.

23 Oct 2018

AbbVie’s U-ACHIEVE Phase 2b/3 dose-ranging study improves outcomes in patients with ulcerative colitis

AbbVie, a research-based global biopharmaceutical company, today announced positive results from U-ACHIEVE, an ongoing Phase 2b/3 dose-ranging study evaluating upadacitinib, an investigational JAK1-selective inhibitor, for induction and maintenance therapy in adult patients with moderately to severely active ulcerative colitis.

23 Oct 2018

Coaching improves medication adherence in people with diabetes, hypertension, high cholesterol

Health Dialog, a leading provider of integrated population health management solutions for health plans, risk-bearing providers and self-insured employers, will release data showing its telephonic health coaching program helped patients managing diabetes, hypertension and high cholesterol achieve a higher rate of adherence than patients without coaching.

23 Oct 2018

OCT News and Research

Targeting specific signaling pathway could provide new avenue for treating fetal alcohol syndrome

MIT neuroscientists discover how the brain overcomes its difficulties

Scientists identify new target for battling deadly form of leukemia

Researchers engineer new 'smart' repellent surface coatings

Hippocampal-avoidance whole-brain radiotherapy better preserves patients' cognitive function

Neurons in the brain's primary visual cortex can reliably detect straight lines

Scientists develop nanodevice to deliver immunotherapy without side effects

Dyslexia gene linked to concussion susceptibility in athletes

Family acceptance of LGBT individual's sexuality linked to lower stress

In-home physical therapy care for knee replacement patients leads to better recovery

Simple technology prevents infectious disease outbreaks in low-resource settings

Fixing Obamacare’s ‘family glitch’ hinges on outcome of November elections

Novel blood test shows promise for monitoring HPV-linked head and neck cancer after treatment

FDA targets 465 websites that sell potentially dangerous, unapproved drugs

Scientists develop new class of compounds for treatment of progressive neurodegenerative disorder

'Brain training' app could help OCD patients to manage symptoms

Advanced breast cancer patients can benefit from immunotherapy-chemotherapy combination

Novartis: Lancet publishes pioneering study of Aimovig’s efficacy in episodic migraine patients

AbbVie’s U-ACHIEVE Phase 2b/3 dose-ranging study improves outcomes in patients with ulcerative colitis

Coaching improves medication adherence in people with diabetes, hypertension, high cholesterol

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News